CD34(+) stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine a is still required to reduce GVHD and morbidity

被引：7

作者：

Noga, SJ ^{[1
]}

Vogelsang, GB ^{[1
]}

Seber, A ^{[1
]}

Davis, JM ^{[1
]}

Schepers, K ^{[1
]}

Hess, AD ^{[1
]}

Jones, RJ ^{[1
]}

机构：

[1] JOHNS HOPKINS BONE MARROW TRANSPLANTAT UNIT, BALTIMORE, MD USA

来源：

TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(96)00442-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：728 / 732

页数：5

共 13 条

[1] PHARMACOKINETICS OF BUSULFAN - CORRELATION WITH VENO-OCCLUSIVE DISEASE IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].

GROCHOW, LB ;

JONES, RJ ;

BRUNDRETT, RB ;

BRAINE, HG ;

CHEN, TL ;

SARAL, R ;

SANTOS, GW ;

COLVIN, OM .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (01) :55-61

[2] SEPARATION OF PLURIPOTENT HEMATOPOIETIC STEM-CELLS FROM SPLEEN COLONY-FORMING CELLS [J].

JONES, RJ ;

WAGNER, JE ;

CELANO, P ;

ZICHA, MS ;

SHARKIS, SJ .

NATURE, 1990, 347 (6289) :188-189

[3]

Martelli M. F., 1996, Experimental Hematology (Charlottesville), V24, P1158

[4]

Noga S. J., 1994, British Journal of Haematology, V87, P41

[5]

Noga S J, 1994, Prog Clin Biol Res, V389, P317

[6]

NOGA SJ, 1993, SEMIN ONCOL, V20, P28

[7]

NOGA SJ, 1996, GRAFT VS HOST DIS, P716

[8]

NOGA SJ, 1991, IN VITRO BONE MARROW, P175

[9]

NOGA SJ, IN PRESS J CLIN ONCO

[10]

REISNER Y, 1994, BLOOD, V84, P346

← 1 2 →